Publication date: 2 October 2026 Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Volume 150 Author(s): Katja Ponzer, Buse Yel Bektash, Martin Lundberg, Fredrik Wikström, Charlotte Gran, Karin Linderståhl, Bonita Palm, Samson Nivins, Kristoffer Månsson, Lina Martinsson, Vincent Millischer, Martin Schalling, Lena Backlund, Catharina Lavebratt
Immunomodulatory effects of lithium treatment in bipolar disorder: A prospective cohort study. // Progress in Neuro-Psychopharmacology & Biological Psychiatry. – URL: https://www.sciencedirect.com/science/article/pii/S0278584626003635?dgcid=rss_sd_all
Immunomodulatory effects of lithium treatment in bipolar disorder: A prospective cohort study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. https://www.sciencedirect.com/science/article/pii/S0278584626003635?dgcid=rss_sd_all
“Immunomodulatory effects of lithium treatment in bipolar disorder: A prospective cohort study.” Progress in Neuro-Psychopharmacology & Biological Psychiatry.
@article{article90513,
title = {Immunomodulatory effects of lithium treatment in bipolar disorder: A prospective cohort study},
journal = {Progress in Neuro-Psychopharmacology \& Biological Psychiatry},
url = {https://www.sciencedirect.com/science/article/pii/S0278584626003635?dgcid=rss_sd_all}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...